BrainStorm (OTC BB: BCLI) is a company that is developing stem cell technologies to provide treatments for currently incurable neurodegenerative diseases. The Company is focused on developing adult stem cells taken from the patient's own bone marrow to treat diseases such as Parkinson's Disease (PD), Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease), and Spinal Cord Injury.

StemSave is the market leader in the recovery and cryo-preservation of stem cells found in the dental pulp of teeth. A collaboration of top stem cell researchers and the dental community, StemSave provides patients, young and old, with a safe and affordable means of preserving their valuable stem cells for future regenerative purposes.

Angioblast Systems, Inc. is a privately held biotechnology company formed in 2001. Angioblast’s lead products are based on commercialization of a unique adult stem cell technology capable of regulating blood vessel growth critical for the treatment of ischemic heart disease and macular degeneration/diabetic eye disease